Selective cyclooxygenase 2 inhibitors for the treatment of rheumatological manifestations of inflammatory bowel disease

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this study is to evaluate the tolerability of COX-2 inhibitors (celecoxib, rofecoxib, valdecoxib, etoricoxib, and lumiracoxib) for the treatment the rheumatological manifestations of IBD and to identify gaps in knowledge that will suggest the most fruitful direction for future research.